Related content

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

By Zhang Jing   Mattison Hayley   Liu Changqin   Ginghina Carmen   Auinger Peggy   McDermott Michael   Stewart Tessandra   Kang Un   Cain Kevin   Shi Min  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 671-682

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination

By Ivanoiu Adrian   Jm Sindic Christian  

Neurocase, Vol. 11, Iss. 1, 2005-02 ,pp. : 32-39

Routledge Ltd

Access to resources Recommend Favorite

Mitochondria: The Common Upstream Driver of Amyloid-&bgr; and Tau Pathology in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 5, 2011-08 ,pp. : 563-572

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegenerative disease biomarkers Aβ_1–40, Aβ_1–42, tau, and p‐tau₁₈₁ in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Profile for Amyloid-β and Tau Expression in Primary Cortical Cultures from 3xTg-AD Mice

By Vale Carmen   Alonso Eva   Rubiolo Juan   Vieytes Mercedes   LaFerla Frank   Giménez-Llort Lydia   Botana Luis  

Cellular and Molecular Neurobiology, Vol. 30, Iss. 4, 2010-05 ,pp. : 577-590

Springer Publishing Company

Access to resources Recommend Favorite